Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene editing
Biotech
Gene editor Scribe slims down workforce as it readies for clinic
The Bay Area biotech is laying off around 20% of its employees as it shifts its focus toward clinical development.
Darren Incorvaia
Jan 8, 2025 5:33pm
Omega halts sole clinical-stage asset to focus on 3 programs
Nov 15, 2024 5:33am
Spanish gene editor licenses DNA-cutting enzymes for up to $43M
Nov 4, 2024 1:46pm
Gene editor Tome laying off 131 workers
Aug 26, 2024 11:03am
8 months after $213M fundraise, gene editor Tome cuts costs
Aug 22, 2024 2:57pm
Bridge RNA from 'jumping genes' could overcome CRISPR limits
Jul 1, 2024 6:55am